Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Metlife ( (MET) ) has provided an announcement.
MetLife, Inc. disclosed preliminary estimates of its variable investment income for the quarter ended June 30, 2025, ranging between $175 million and $225 million pre-tax. These figures, which include income from private equity, real estate, and other funds, are unaudited and subject to change as the company has not completed its financial closing procedures. Stakeholders are advised to be cautious in relying on these preliminary results, as they are not indicative of future performance and may differ from the final audited figures.
The most recent analyst rating on (MET) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.
Spark’s Take on MET Stock
According to Spark, TipRanks’ AI Analyst, MET is a Outperform.
MetLife’s strong financial performance, reasonable valuation, and positive earnings call sentiment contribute significantly to its overall score. While technical analysis indicates stability, the main strengths lie in robust cash flow management and strategic risk management initiatives. Minor challenges are noted but are outweighed by the company’s strengths.
To see Spark’s full report on MET stock, click here.
More about Metlife
MetLife, Inc. operates in the financial services industry, focusing on providing insurance, annuities, employee benefits, and asset management services. The company is a prominent player in the global insurance market.
Average Trading Volume: 3,487,512
Technical Sentiment Signal: Buy
Current Market Cap: $53.17B
See more insights into MET stock on TipRanks’ Stock Analysis page.